Endocrine Disrupting Chemicals: Sources, Effects And Treatments

Muhammad Aqeel Ashraf; Mesmire Wilson

doi:10.2478/acmy-2019-0010

Abstract

Hormonal changes in humans and animals can be attributed to endocrine disrupting chemicals (EDCs). Studies have found that excessive exposure to natural and artificial environmental chemicals and toxins can have adverse effects on the endocrine system and reproductive health. The endocrine system creates and releases hormones that regulate the development of organs and how they function. Any disruption to hormones affects the development and functioning of the reproductive system, the brain and the neurological system. Research and reports on the subject have been published by international experts and organizations including the World Health Organization (WHO), United Nations Environment Programme (UNEP), International Labour Organization (ILO) and Endocrine Society. To fully comprehend the effect of EDCs on humans and wildlife, it is essential to understand epigenetics and its transgenerational effects on hormone development. Here, we extensively explore and review the research on the sources of EDCs, their effects and why exposure to EDCs is of concern, and treatments for EDC exposure.

References

[1] A. Bergman, Jerrold, J.J. Heindel, S. Jobling, K.A. Kidd, and R.T. Zoeller, “State of the Science of Endocrine Disrupting Chemicals- An Assessment of the State of the Science of Endocrine Disruptors Prepared by a Group of Experts for the United Nations Environment Programme (UNEP) and WHO”, Geneva, Switzerland, 2012.10.1016/j.toxlet.2012.03.020
Search in Google Scholar Back to article
[2] EC - European Commission. “Impact of endocrine disruptors on human health and wildlife”, Weybridge, UK, 1996.
Search in Google Scholar Back to article
[3] R. Newbold, “Prenatal exposure to diethylstilbestrol (DES)”, Fertility and sterility, Vol. 89, Pp. 55-56, 2008.10.1016/j.fertnstert.2008.01.062
Search in Google Scholar Back to article
[4] M. Shahidehnia, “Epigenetic Effects of Endocrine Disrupting Chemicals”, Journal of Environmental & Analytical Toxicology, 2016.10.4172/2161-0525.1000381
Search in Google Scholar Back to article
[5] D.E.J. Bourguignon, L.C. Giudice, R. Hauser, G.S. Prins, A.M. Soto, R. Thomas Zoeller, and A.C. Gore, “Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement”, Endocrine Reviews, Vol. 30, No. 4, Pp. 293-342, 2009.10.1210/er.2009-0002
Search in Google Scholar Back to article
[6] M.K. Skinner, M. Manikkam, and C. Guerrero-Bosagna, “Epigenetic transgenerational actions of endocrine disruptors”, Reproductive Toxicology, Vol. 31, No. 3, Pp. 337-343, 2011.10.1016/j.reprotox.2010.10.012
Search in Google Scholar Back to article
[7] G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. van der Saag, B. van der Burg, and J.A. Gustafsson, “Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor”, Endocrinology, Vol. 139, Pp. 4252–4263, 1998.
Search in Google Scholar Back to article
[8] S.M. Dickerson, and A.C. Gore, “Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle”, Rev Endocr Metab Disord., Vol. 8, Pp. 143–159, 2007.10.1007/s11154-007-9048-y
Search in Google Scholar Back to article
[9] Y. Cao, A.M. Calafat, D.R. Doerge, D.M. Umbach, J.C. Bernbaum, N.C. Twaddle, X. Ye, and W.J. Rogan, “Isoflavones in urine, saliva and blood of infants—data from a pilot study on the estrogenic activity of soy formula”, J. Expo. Sci. Environ Epidemiol., Vol. 19, Pp. 223–234, 2009.10.1038/jes.2008.44
Search in Google Scholar Back to article
[10] S. Melmed, and R.H. Williams, “Williams textbook of Endocrinology”, Philadelphia, PA, Elsevier/Saunders, 2011.
Search in Google Scholar Back to article
[11] M.M. Mahoney, and V. Padmanabhan, “Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus”, Toxicology and Applied Pharmacology, Vol. 247, No. 2, Pp. 98-104, 2010.10.1016/j.taap.2010.05.017
Search in Google Scholar Back to article
[12] H.N. Sarma, M. Manikkam, C. Herkimer, J. Dell’Orco, K.B. Welch, D.L. Foster, and V. Padmanabhan, “Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not folliclestimulating hormone responsiveness, to estradiol negative feedback in the female”, Endocrinology, Vol. 146, No. 10, Pp. 4281-4291, 2005.
Search in Google Scholar Back to article
[13] A. Janesick, and B. Blumberg, “Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity”, Birth Defects Research, Part C: Embryo Today--Reviews, Vol. 93, No. 1, Pp. 34-50, 2011.10.1002/bdrc.20197
Search in Google Scholar Back to article
[14] M.A. Hanson, and P.D. Gluckman, “Developmental origins of health and disease: moving from biological concepts to interventions and policy”, International Journal of Gynaecology and Obstetrics, Vol. 115, No. 1, Pp. S3-5, 2011.10.1016/S0020-7292(11)60003-9
Search in Google Scholar Back to article
[15] R. Klein, “History of congenital hypothyroidism In :(Burrow GN, Dussault JH eds.)”, Neonatal Thyroid Screening, pp. 51-59. New York, Raven Press, 1980.
Search in Google Scholar Back to article
[16] C. Casals-Casas, and B. Desvergne, “Endocrine disruptors: from endocrine to metabolic disruption”, Annual Review of Physiology, Vol. 73, Pp. 135-162, 2011.10.1146/annurev-physiol-012110-14220021054169
Search in Google Scholar Back to article
[17] L.N. Vandenberg, T. Colborn, T.B. Hayes, J.J. Heindel, D.R. Jacobs, D.H. Lee, T. Shioda, A.M. Soto, F.S. vom Saal, W.V. Welshons, R.T. Zoeller, and J.P. Myers, “Hormones and endocrine-disrupting chemicals: Lowdose effects and nonmonotonic dose responses”, Endocrine Reviews, Vol. 33, No. 3, Pp. 378-455, 2012.10.1210/er.2011-1050336586022419778
Search in Google Scholar Back to article
[18] J.W. Owens, and J.G. Chaney, “Weighing the results of differing ‘low dose’ studies of the mouse prostate by Nagel, Cagen, and Ashby: Quantification of experimental power and statistical results”, Regulatory Toxicology and Pharmacology, Vol. 43, No. 2, Pp. 194-202, 2005.10.1016/j.yrtph.2005.07.00116140446
Search in Google Scholar Back to article
[19] P. Alonso-Magdalena, E. Vieira, S. Soriano, L. Menes, D. Burks, I. Quesada, and A. Nadal, “Bisphenol A Exposure during Pregnancy Disrupts Glucose Homeostasis in Mothers and Adult Male Offspring”, Environmental Health Perspectives, Vol. 118, No. 9, Pp. 1243-1250, 2010.
Search in Google Scholar Back to article
[20] G.S. Prins, W.Y. Tang, J. Belmonte, and S.M. Ho, “Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis”, Basic and Clinical Pharmacology and Toxicology, Vol. 102, No. 2, Pp. 134-138, 2008.10.1111/j.1742-7843.2007.00166.x281939218226066
Search in Google Scholar Back to article
[21] R. Elsby, J.L. Maggs, J. Ashby, D. Paton, J.P. Sumpter, and B.K. Park, “Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: A two stage approach coupling human liver microsomes and a yeast estrogenicity assay”, Pharmacology and Experimental Therapeutics, Vol. 296, No. 2, Pp. 329-337, 2001.
Search in Google Scholar Back to article

Endocrine Disrupting Chemicals: Sources, Effects And Treatments

Abstract

Paradigm

My account